Cite Filings / ONC / 0001047469-19-006397
Feed Companies Filings Check
Sign in
PRE 14A

Proxy Statement (Preliminary)

BeOne Medicines Ltd. · Filed 2019-11-19 · Acc 0001047469-19-006397

Documents 1

  • PRE 14A Proxy Statement (Preliminary) , a2240110zpre14a.htm

Around this filing

  • 2020-03-30 PRE 14A Proxy Statement (Preliminary)
  • 2019-11-20 4 CFO & Chief Strategy Officer sold 25,000 shares at an average $194.34 ($4,858,616)
  • 2019-11-20 4 CMO, Hematology sold 1,500 shares at an average $194.49 ($291,740)
  • 2019-11-19 PRE 14A Proxy Statement (Preliminary)
  • 2019-11-18 4 Director sold 13,000 shares at an average $194.63 ($2,530,198)
  • 2019-11-18 4 President & GM China sold 1,000 shares at $202.05 ($202,050)
  • 2019-04-11 PRE 14A Proxy Statement (Preliminary)

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading a2240110zpre14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…